BOOK

FindCenter AddIcon
Book Image

Good Chemistry: The Science of Connection, From Soul to Psychedelics

Book Image

By Julie Holland — 2024

A psychiatrist and psychedelic researcher explores the science of connection—why we need it, how we’ve lost it, and how we might find it again. We are suffering from an epidemic of disconnection that antidepressants and social media can’t fix. See more...

FindCenter Video Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

FindCenter AddIcon
FindCenter Video Image
49:53

How Do Psychedelic Drugs Work on the Brain?

Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.

FindCenter AddIcon
FindCenter Video Image
01:32:51

Dr. Robin Carhart-Harris: Can Psychedelics Cure Depression?

Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.

FindCenter AddIcon
FindCenter Video Image
29:53

Dr Robin Carhart-Harris - A Unified Model of the Brain Action of Psychedelics

REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.

FindCenter AddIcon
FindCenter Video Image
58:45

Robin Carhart-Harris: Brain Imaging Studies with Psilocybin and MDMA

Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.

FindCenter AddIcon
FindCenter Video Image

DMT Alters Cortical Travelling Waves

These results support a recent model proposing that psychedelics reduce the ‘precision-weighting of priors’, thus altering the balance of top-down versus bottom-up information passing.

FindCenter AddIcon
FindCenter Video Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

FindCenter AddIcon
FindCenter Video Image

DMT Models the Near-Death Experience

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).

FindCenter AddIcon
FindCenter Video Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

FindCenter AddIcon
FindCenter Video Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

FindCenter AddIcon

EXPLORE TOPIC

Belonging